In the news

October 29, 2024

WGHI-supported research could lead to blood tests for early breast cancer diagnoses

Using a highly promising approach to speed breast cancer diagnostics, researcher W. Andy Tao of the Purdue Institute for Cancer Research is studying how specific blood particles could be used to catch BRCA-related breast cancer before any tumor growth.

August 27, 2024

Tool developed by PICR member reveals untapped efficacy of cancer drug, leveling up cancer fight

Research from Majid Kazemian in collaboration with the National Institutes of Health (NIH) reveals that a cancer drug dismissed by traditional testing methods may be effective in treating bladder cancer, thanks to a new computational tool called the Pathway Ensemble Tool (PET).

Cancer researchers awarded funds from Purdue Innovates to strengthen market readiness of their work

Andrea Kasinski, Yoon Yeo and Jesse Chi Zhang have received support from the Trask Innovation Fund to further develop disease-fighting innovations for commercial use.

Sintim team develops compound to treat drug-resistant acute myeloid leukemia

Purdue researchers have developed a patent-pending compound designed to treat drug-resistant acute myeloid leukemia. PICR member Herman Sintim leads the team.

Team is using mass spectrometry to help surgeons quickly identify tumor tissue during brain surgery

PICR member R. Graham Cooks is working with a team of researchers from Purdue and Mayo Clinic to help surgeons rapidly identify mutations and improve tumor tissue removal during brain cancer surgery.

Genetically engineering a treatment for incurable brain tumors

Glioblastomas are almost always lethal. Traditional treatment methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective. A team of Purdue researchers, led by cancer institute member Sandro Matosevic, is developing a patent-pending treatment.

First annual PICR Awards ceremony recognizes excellence in cancer research

In a significant milestone for the Purdue Institute for Cancer Research (PICR), faculty, students and staff gathered at the Hansen Life Sciences Research Building on April 17 to honor seven awardees for their outstanding contributions to cancer research.

Yoon Yeo and team create biocompatible nanoparticles to enhance systemic delivery of cancer immunotherapy

Immunotherapy is a promising approach to fighting cancer. A team led by Yoon Yeo of the Purdue Institute for Cancer Research, Purdue University College of Pharmacy, and Purdue Institute for Drug Discovery, is developing nanoparticles to make it even better. These innovative researchers are developing and validating patent-pending nanoparticles modified with adenosine triphosphate, or ATP, to enhance immunotherapy effects against malignant tumors.

Low to be honored by American Lung Association for cancer-fighting invention

The American Lung Association in Indiana will honor Purdue University researcher Philip Low on April 13 at its annual gala in Indianapolis for his invention of CYTALUX, which helps in the fight against lung cancer.

Pamala Morris named associate director of inclusive excellence

The Purdue Institute for Cancer Research (PICR) is excited to announce the appointment of Pamala Morris as its first associate director of inclusive excellence.